https://orcid.org/0000-0002-7353-0817
References
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;0(0):1–464.
- Mainz JG, Naehrlich L, Schien M, et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax. 2009;64(6):535–540.
- Doht F, Hentschel J, Fischer N, et al. Reduced effect of intravenous antibiotic treatment on sinonasal markers in pulmonary inflammation. Rhinology [Internet]. 2015;53(3):249–259.
- Kim RJT, Park L, Wood AJ, et al. Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity. Int Forum Allergy Rhinol. 2015;5(5):380–385.
- Werner E, Roe F, Bugnicourt A, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2004;70(10):6188–6196.
- Knafl D, Thalhammer F, Vossen MG. In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment. PLoS One. 2017;12(7):e0181090.
- Hengzhuang W, Wu H, Ciofu O, et al. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2011;55:4469–4474.
- Aanaes K, von Buchwald C, Hjuler T, et al. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis. Am J Rhinol Allergy. 2013;27(1):1–4.
- Aanaes K, Alanin MC, Nielsen KG, et al. The accessibility of topical treatment in the paranasal sinuses on operated cystic fibrosis patients assessed by scintigraphy*. Rhinology. 2018;56(3):268–273.
- Ozaki S, Saito A, Nakaminami H, et al. Comprehensive evaluation of fibrin glue as a local drug-delivery system - efficacy and safety of sustained release of vancomycin by fibrin glue against local methicillin-resistant Staphylococcus aureus infection. J Artif Organs. 2014;17(1):42–49.
- Aanaes K, Johansen HK, Skov M, et al. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients — can chronic lung infections be postponed? Rhinology. 2013;51(3):222–230.
- Herrmann G, Yang L, Wu H, et al. Colistin‐tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202(10):1585–1592.
- Berkhout MC, van Velzen AJ, Touw DJ, et al. Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis. J Antimicrob Chemother. 2014;69:3112–3115.
- Lee VS, Davis GE. Culture-directed topical antibiotic treatment for chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(6):414–417.
- Fong SA, Drilling A, Morales S, et al. Activity of bacteriophages in removing biofilms of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients. Front Cell Infect Microbiol. 2017;7:418.
- Hashemi MM, Holden BS, Taylor MF, et al. Antibacterial and antifungal activities of poloxamer micelles containing ceragenin CSA-131 on ciliated tissues. Molecules. 2018;23(3):596.
- Cho DY, Lim DJ, Mackey C, et al. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms. Int Forum Allergy Rhinol. 2019;9(5):486–492.
- Lim DJ, Skinner D, Mclemore J, et al. In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms. Int Forum Allergy Rhinol. 2020;10(1):121–127.
- Fung M, Babik J, Humphreys IM, et al. Diagnosis and treatment of acute invasive fungal sinusitis in cancer and transplant patients. Curr Infect Dis Rep. 2019;21(12):53.
- Ortiz E, Ng RTY, Alliegro FC, et al. Microbiology of rhinosinusitis in immunosupressed patients from the University hospital. Braz J Otorhinolaryngol. 2011;77:522–525.